Triamcinolone acetonide extended-release injectable suspension (TA-ER) is associated with reduced blood glucose elevation vs. standard triamcinolone in type 2 diabetes mellitus patients with knee osteoarthritis: a randomized, blinded, parallel-group study
| Autor: | R. Sala, R. Manning, S.J. Russell, Scott Kelley, Joelle Lufkin, J.R. Johnson, G. Habib, Y. Davis, P.G. Conaghan, Alan Kivitz, Q. Vo |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
030203 arthritis & rheumatology
medicine.medical_specialty Triamcinolone acetonide Group study business.industry Biomedical Engineering Urology Type 2 Diabetes Mellitus 030209 endocrinology & metabolism Osteoarthritis Extended release injectable suspension medicine.disease 03 medical and health sciences 0302 clinical medicine Rheumatology medicine Orthopedics and Sports Medicine business medicine.drug |
| Zdroj: | Osteoarthritis and Cartilage. 26:S230 |
| ISSN: | 1063-4584 |
| DOI: | 10.1016/j.joca.2018.02.481 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect